What is it about?
Many Muslims with Type II diabetes choose to observe the religious fast during Ramadan. However, even among those with stable levels of blood glucose, the management of Type II diabetes can be challenging. With only two meals per day and no food during daylight, large swings in blood glucose levels may occur due to the long gap between meals, larger amounts of food consumed, and the lack of oral antidiabetes drugs during daylight.
Featured Image
Photo by aboodi vesakaran on Unsplash
Why is it important?
This sub-analysis of the international DIA-RAMADAN study examined the real-world safety and effectiveness of gliclazide modified release (MR) 60 mg among fasting patients with Type II diabetes in Bangladesh.
Perspectives
Assessed the effectiveness and safety of gliclazide modified release (MR) 60 mg in the Bangladeshi diabetic patients during Ramadan.
Dr. Murshed Ahamed Khan
Read the Original
This page is a summary of: Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study, Journal of Comparative Effectiveness Research, February 2024, Becaris Publishing Limited,
DOI: 10.57264/cer-2023-0132.
You can read the full text:
Contributors
The following have contributed to this page
